| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
52,775,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
1,247,701 |
Avg
Vol: |
599,363 |
| 52
Week Range: |
$10.49 - $10.49 |
|
| Level
I Sector: |
Information Technology |
| Level
II Sector: |
Electronics |
| Level
III Sector: |
Scientific & Technical Instruments |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2007-10-15 |
4 |
S |
$5.98 |
$54,265 |
D/D |
(9,000) |
544,709 |
|
- |
|
| Higgins Thomas T |
Chief Financial Officer |
• – – |
2007-10-10 |
4 |
D |
$6.13 |
$6,087 |
D/D |
(993) |
29,170 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2007-09-14 |
4 |
S |
$5.40 |
$10,836 |
D/D |
(2,000) |
553,709 |
|
- |
|
| Mcaree Peter F |
Vice President of Finance |
• – – |
2007-09-10 |
4 |
S |
$5.53 |
$15,561 |
D/D |
(2,801) |
28,327 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2007-09-07 |
4 |
S |
$5.65 |
$9,492 |
D/D |
(1,680) |
555,709 |
|
- |
|
| Mcaree Peter F |
Vice President of Finance |
• – – |
2007-09-06 |
4 |
S |
$5.75 |
$1,553 |
D/D |
(270) |
31,128 |
|
- |
|
| Creager Stephen E |
VP and General Counsel |
• – – |
2007-08-23 |
4 |
S |
$5.72 |
$17,317 |
D/D |
(3,000) |
13,211 |
|
- |
|
| Creager Stephen E |
VP and General Counsel |
• – – |
2007-08-22 |
4 |
S |
$5.65 |
$17,041 |
D/D |
(3,000) |
16,211 |
|
- |
|
| Higgins Thomas T |
Chief Financial Officer |
• – – |
2007-08-17 |
4 |
D |
$5.69 |
$6,100 |
D/D |
(1,072) |
27,038 |
|
- |
|
| Mcaree Peter F |
Vice President of Finance |
• – – |
2007-08-17 |
4 |
D |
$5.69 |
$2,259 |
D/D |
(397) |
31,398 |
|
- |
|
| Creager Stephen E |
VP and General Counsel |
• – – |
2007-08-17 |
4 |
D |
$5.69 |
$6,868 |
D/D |
(1,207) |
19,211 |
|
- |
|
| Bal Bruce J |
VP, Operations & Service |
• – – |
2007-08-17 |
4 |
D |
$5.69 |
$6,100 |
D/D |
(1,072) |
53,999 |
|
- |
|
| Hrusovsky E Kevin |
President & CEO |
• • – |
2007-07-30 |
4 |
OE |
$4.86 |
$97,200 |
D/D |
20,000 |
206,453 |
|
- |
|
| Creager Stephen E |
VP and General Counsel |
• – – |
2007-07-30 |
4 |
D |
$4.86 |
$11,732 |
D/D |
(2,414) |
17,043 |
|
- |
|
| Mcaree Peter F |
Vice President of Finance |
• – – |
2007-07-30 |
4 |
D |
$4.86 |
$6,945 |
D/D |
(1,429) |
30,545 |
|
- |
|
| Bal Bruce J |
VP, Operations & Service |
• – – |
2007-07-30 |
4 |
D |
$4.86 |
$10,420 |
D/D |
(2,144) |
51,696 |
|
- |
|
| Higgins Thomas T |
Chief Financial Officer |
• – – |
2007-07-10 |
4 |
D |
$4.48 |
$4,449 |
D/D |
(993) |
24,735 |
|
- |
|
| Higgins Thomas T |
Chief Financial Officer |
• – – |
2007-04-10 |
4 |
D |
$5.72 |
$5,680 |
D/D |
(993) |
22,603 |
|
- |
|
| Bal Bruce J |
VP, Operations & Service |
• – – |
2007-03-29 |
4 |
D |
$5.54 |
$6,836 |
D/D |
(1,234) |
43,066 |
|
- |
|
| Creager Stephen E |
VP and General Counsel |
• – – |
2007-03-29 |
4 |
D |
$5.54 |
$7,662 |
D/D |
(1,383) |
12,707 |
|
- |
|
| Hrusovsky E Kevin |
President & CEO |
• • – |
2007-03-29 |
4 |
OE |
$5.54 |
$49,860 |
D/D |
9,000 |
182,013 |
|
- |
|
| Mcaree Peter F |
Vice President of Finance |
• – – |
2007-03-29 |
4 |
D |
$5.54 |
$2,632 |
D/D |
(475) |
26,939 |
|
- |
|
| Higgins Thomas T |
Chief Financial Officer |
• – – |
2007-03-29 |
4 |
D |
$5.54 |
$6,498 |
D/D |
(1,173) |
18,532 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2007-03-29 |
4 |
D |
$5.54 |
$5,257 |
D/D |
(949) |
557,389 |
|
- |
|
| Higgins Thomas T |
Chief Financial Officer |
• – – |
2007-01-10 |
4 |
D |
$5.76 |
$6,831 |
D/D |
(1,186) |
20,471 |
|
- |
|
291 Records found
|
|
Page 10 of 12 |
|
|
